JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win
Source link
July 11, 2025
- Forget ransomware – most firms think quantum computing is the biggest security risk to come
- How Iconiq, wealth firm backed by Zuckerberg, brings rich donors together
- Intel CEO reportedly admits ‘it is too late for us’ to catch AI leaders like Nvidia, but here’s how it could still recover
- FDA to consider drug affordability when speeding up approvals: Makary
